AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$621M |
| 2 |
Visa
V
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$542M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$525M |
| 5 |
Amazon
AMZN
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$693M |
| 2 |
Texas Instruments
TXN
|
+$477M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$235M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Healthcare | 14.87% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Financials | 12.61% |
| 5 | Communication Services | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Opko Health
OPK
$1.1B
| $3.28M | ﹤0.01% |
897,900
+300,000
| +50% | +$1.12M |
|
1852
Glaukos
GKOS
$9.32B
| $3.28M | ﹤0.01% |
68,005
-2,370
| -3% | -$131K |
|
1853
Hecla Mining
HL
$9.32B
| $3.27M | ﹤0.01% |
595,182
-181,402
| -23% | -$1.13M |
|
|
BECN
1854
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $3.27M | ﹤0.01% |
68,443
| – | – |
|
1855
Marathon Digital Holdings
MARA
$3.93B
| $3.27M | ﹤0.01% |
103,450
-21,750
| -17% | -$707K |
|
|
SFIX
1856
Stitch Fix
SFIX
$564M
| $3.26M | ﹤0.01% |
81,680
-9,120
| -10% | -$426K |
|
1857
Medifast
MED
$107M
| $3.26M | ﹤0.01% |
16,924
-1,750
| -9% | -$430K |
|
|
AXNX
1858
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.25M | ﹤0.01% |
50,000
-1,300
| -3% | -$88.7K |
|
|
NXGN
1859
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $3.25M | ﹤0.01% |
230,764
-4,960
| -2% | -$77.1K |
|
1860
iShares Russell Mid-Cap ETF
IWR
$56.1B
| $3.21M | ﹤0.01% |
40,984
+4,942
| +14% | +$396K |
|
|
CVSA
1861
Covista Inc
CVSA
$4.5B
| $3.2M | ﹤0.01% |
84,705
-44,432
| -34% | -$1.65M |
|
1862
Prothena Corp
PRTA
$441M
| $3.2M | ﹤0.01% |
44,940
-4,600
| -9% | -$286K |
|
|
DEA
1863
Easterly Government Properties
DEA
$1.18B
| $3.2M | ﹤0.01% |
61,958
-4,136
| -6% | -$224K |
|
|
SRNE
1864
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.2M | ﹤0.01% |
419,200
+93,400
| +29% | +$792K |
|
1865
RE/MAX Holdings
RMAX
$197M
| $3.19M | ﹤0.01% |
102,523
-2,658
| -3% | -$88.3K |
|
|
P
1866
Everpure Inc
P
$23.5B
| $3.19M | ﹤0.01% |
126,936
-1,862
| -1% | -$41.1K |
|
|
CVA
1867
DELISTED
Covanta Holding Corporation
CVA
| $3.19M | ﹤0.01% |
158,500
+2,200
| +1% | +$43.5K |
|
1868
Schrodinger
SDGR
$1.12B
| $3.19M | ﹤0.01% |
58,264
| – | – |
|
1869
Protolabs
PRLB
$1.72B
| $3.18M | ﹤0.01% |
47,788
-1,835
| -4% | -$143K |
|
1870
Gibraltar Industries
ROCK
$1.29B
| $3.18M | ﹤0.01% |
45,683
-6,250
| -12% | -$450K |
|
1871
Evolent Health
EVH
$391M
| $3.17M | ﹤0.01% |
102,200
-5,500
| -5% | -$132K |
|
1872
Cavco Industries
CVCO
$4.4B
| $3.16M | ﹤0.01% |
13,365
-400
| -3% | -$96.2K |
|
1873
SiTime
SITM
$13.9B
| $3.15M | ﹤0.01% |
15,450
+1,400
| +10% | +$250K |
|
1874
Algonquin Power & Utilities
AQN
$4.66B
| $3.15M | ﹤0.01% |
215,005
+4,091
| +2% | +$63.1K |
|
1875
iShares Core S&P Small-Cap ETF
IJR
$109B
| $3.15M | ﹤0.01% |
28,852
-318,082
| -92% | -$35M |
|
Similar funds
AllianceBernstein's Q3 2021 Portfolio in Review
As of Q3 2021, AllianceBernstein held 3,430 positions worth $253B, up 1.8% from $249B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
AllianceBernstein's Q3 2021 filing shows 114 new, 1,102 increased, 1,623 reduced and 152 closed positions. Its largest new stake was Freshworks: 2,094,708 shares worth $89.4M. The largest sale was Alphabet (Google) Class C, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q3 2021 buy was Freshworks: 2,094,708 shares worth $89.4M.
- AllianceBernstein added most to Qualcomm in Q3 2021, an estimated $621M increase.
- AllianceBernstein's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $693M.
- AllianceBernstein fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $230M.
- AllianceBernstein's ten largest holdings make up 25% of its $253B portfolio in Q3 2021.
- AllianceBernstein opened 114 new positions and closed 152 in Q3 2021.
- AllianceBernstein's portfolio value rose 1.8% quarter-over-quarter to $253B.
Based on AllianceBernstein's 13F filing for Q3 2021, filed 10 Nov 2021.